2018

alvaro-monteiro-rivkin-grant

Alvaro Monteiro, Ph.D.

August 16, 2019

Alvaro Monteiro, Ph.D.H. Lee Moffitt Cancer Center & Research InstituteTampa, FL, United States Project: Tackling PARP inhibitor resistance through functional proteomics Research Areas: Chemotherapy Resistance Summary:There has been significant progress in ovarian cancer treatment especially with the development and approval of PARP inhibitor drugs. Despite this progress, a sizable percentage of patients do not respond or stop […]

Read More
John-Liao-Rivkin-Grant

John Liao, M.D., Ph.D.

August 16, 2019

John Liao, M.D., Ph.D.University of Washington2018 James A. Harting Pilot Study Award   Development of a vaccine to prevent serous tubal intraepithelial carcinoma High grade serous ovarian cancer does not originate in the ovary, as once thought, but on the fallopian tube. Precancerous fallopian tube cells (called serous tubal intraepithelial carcinoma or STIC) can go through […]

Read More
susan-ramus-rivkin-grant

Susan J Ramus, PhD

August 16, 2019

Susan J Ramus, PhDThe University of New South Wales  Genetic susceptibility to non-high grade serous ovarian cancer Ovarian cancer consists of five distinct types of cancers that have different clinical characteristics, patient outcomes, and even begin in different nearby organs. They have different changes in the DNA of the tumor cells which affect the biology […]

Read More
dan-peer-pilot-award

Dan Peer, Ph.D.

August 16, 2019

Dan Peer, Ph.D.Tel Aviv UniversityTel Aviv, Israel Project: Developing a novel therapeutic modality to chemo-resistance epithelial ovarian cancer. Research Areas: Novel Therapy, Chemotherapy Resistance Summary:Chemotherapy resistance is one of the biggest challenges for the treatment of epithelial ovarian cancer. One promising method to reliably test new anticancer drugs and understand response to chemotherapy is to develop 3-dimentional […]

Read More

Angela Russo, Ph.D

August 16, 2019

Angela Russo, Ph.DUniversity of Illinois at Chicago – UICChicago, IL, United States2018 MARLYS CHENEY PILOT AWARD Project: Characterization and targeting the markers of stemness altered during ovarian cancer pathogenesis using WNT inhibitors Research Areas: Cell Biology, Stem Cells, Tumor Microenvironment Summary:High-grade serous ovarian cancer is the most common type of ovarian cancer with the highest mortality rate. […]

Read More